baber/WOPTO huggingface dataset:
Patent CA-2754727-A1 (CA)
Inventor: ROMETTY JOHN A
IPC: B65D5/00
Filed: 2010-03-16
Abstract: A four-sided, clam-shell-like container (10) is formed from a preformed, rigid U-shaped cross-section.  The U-shaped member (11) has a base wall (20) and op-posing side walls (22,24). The base and side walls and the intersection of the base and side walls are rigid. The base wall has a thickness having a slot (28) is formed therein.  The slot extends longitudinally along a length of the base wall and is formed in an inner surface thereof into the thickness of the base wall. The slot defines base wall sec-tions (20a, 20b) adjacent and connected to one another by a portion of the thickness of the base wall. The base wall portions (20a, 20b) and the side walls adjacent thereto are foldable inward along the slot so as to form a four-sided, generally rectangular shaped cross-section container such that ends of the side walls are near one another and are foldable outward for stacking and storing the U-shaped members.
Patent CA-2754739-A1 (CA)
Inventor: GRAY JOHN F
IPC: A61M5/14
Filed: 2003-12-03
Abstract: A drive mechanism for delivery of infusion medium a coil capable of being electrically activated to provide an electromagnetic field. The coil surrounds a piston channel extending in an axial direction. An armature is located adjacent the coil, on one side of the axial channel. The armature is moveable toward a forward position, in response to the electromagnetic field produced by activation of the coil. A piston is located within the piston channel and is moveable axially within the channel to a forward position, in response to movement of the armature to its forward position. The armature and piston are moved toward a retracted position, when the coil is not energized. The armature may be configured with a reduced diameter by including a coil cup for supporting the coil including a shelf portion defining at least a portion of a pole surface of the coil cup.
Patent CA-2755364-A1 (CA)
Inventor: GROLL HENNING
IPC: G01N33/487
Filed: 2010-03-25
Abstract: The present invention provides a system of biosensors whose dose-response curves are maintained within a predetermined and desired range or tolerance during production by selecting a feature of the biosensors that can be varied during production. For example, in one exemplary embodiment the effective area of the working electrode of an electrochemical biosensor can be varied during production as needed to offset variations that occur, e.g., in the reagent of the biosensors as production proceeds.  In another exemplary embodiment, the dose-response curve of biosensors not yet produced can be predicted and one or more features of these biosensors can be selected to maintain the dose-response curve within a predetermined range or tolerance.
Patent CA-2755551-A1 (CA)
Inventor: SCHAFER BRADLEY JOHN
IPC: H02J13/00
Filed: 2010-04-08
Abstract: A communication and control system for a high voltage power line using an energy harvesting power supply to avoid batteries in the communication components maintained at line voltage. The energy harvesting power supply utilizes scavenged backscatter power received from a transceiver maintained at ground potential or a power supply with a super-saturating magnetic flux core, such as a mu-metal core, to harvest electromagnetic field energy from the power line. The communication equipment maintained at line voltage communicates information to the transceiver maintained at ground potential by modulating backscatter energy reflected from the beam transmitted by the ground level transceiver to minimize the power requirement of the communication equipment maintained at line voltage. Response equipment includes capacitors, voltage regulator, voltage sag supporter, circuit interrupter, remote communication equipment, reporting and analysis system.
Patent CA-2755557-A1 (CA)
Inventor: TUCKER MICHAEL
IPC: B64C3/34
Filed: 2010-03-31
Abstract: A wing structure (10) is provided, wherein the wing structure comprises; an upper covering (13), a lower covering (14), and a spar (20), the spar comprising; a spar web (21), an upper spar cap (22) attached to the upper covering, and a lower spar cap (23) attached to the lower covering, the wing structure also comprising a face spaced apart from the spar web extending be-tween the upper and lower spar caps. The wing structure is arranged to contain fuel in a fuel containment area (70) between the upper and lower coverings on one side of the spar web. The upper and lower spar caps extend from the spar web only on the other side of the spar web to the fuel containment area.
Patent CA-2755947-A1 (CA)
Title: Circuit hydraulique d'actionnement d'un atterrisseur et procedes de deploiement et de relevage d'un atterrisseur utilisant un tel circuit
Inventor: ERNIS SEBASTIEN
IPC: B64C25/22
Filed: 2011-10-18
Abstract: L'invention propose un circuit hydraulique pour l'actionnement d'un atterrisseur comprenant une ligne d'alimentation en fluide et une ligne de retour, au moins un sélecteur de porte, connecté aux lignes d'alimentation et de retour, qui alimente des lignes de service de portes, dont une ligne d'ouverture des portes et une ligne de fermeture des portes, au moins un sélecteur d'atterrisseur, connecté aux lignes d'alimentation et de retour, qui alimente des lignes de service d'atterrisseur dont une ligne de déploiement et une ligne de relevage de l'atterrisseur, une ligne de décrochetage des portes et une ligne de décrochetage de l'atterrisseur. Selon l'invention, la ligne de décrochetage des portes est connectée à au moins une ligne de service d'atterrisseur tandis que la ligne de décrochetage de l'atterrisseur est connectée à au moins une ligne de service de portes, le circuit comportant en outre des moyens pour connecter les lignes de service de portes entre elles lors d'une phase d'ouverture des portes, et des moyens pour connecter les lignes de service d'atterrisseur entre elles lors d'une phase de déploiement de l'atterrisseur.
Patent CA-2757368-A1 (CA)
Inventor: SCHIEMANN KAI
IPC: A61P9/00
Filed: 2010-03-03
Abstract: The present invention relates to piperidine and pyrazine derivatives according to formulae (Ia), (Ib) and (II) as autotaxin in-hibitors and the use of such com-pounds for the treatment and/or pro-phylaxis of physiological and/or pathophysiological conditions, which are caused, mediated and/or propa-gated by increased lysophosphatic acid levels and/or the activation of autotaxin, in particular of different cancers.
Patent CA-2758658-A1 (CA)
Title: Methods of identifying high neutron capture cross section doped proppant in induced subterranean formation fractures
Inventor: DUENCKEL ROBERT
IPC: G01V5/10
Filed: 2010-03-30
Abstract: Methods are provided for determining the locations and heights of fractures in a subterranean formation us-ing a neutron-emitting logging tool.    Uti-lizing predetermined relationships (1) be-tween logging tool count rates and associ-ated apparent formation hydrogen index values and (2) between logging tool count rate ratios and associated apparent forma-tion hydrogen index values, the methods detect the presence and heights in the for-mation of proppant containing high ther-mal neutron capture cross section material in a manner substantially eliminating proppant determination uncertainty result-ing from a prior change in formation hy-drogen index values. A second, associat-ed, method employing logging tool count rates and count rate ratios to determine the presence of proppant containing high thermal neutron capture cross section ab-sorbers utilizes a crossplot of count rate versus ratio. Logged intervals containing no proppant will fall on a trend/trendline on the crossplot, whereas logged intervals containing proppant will fall off from this trend/trendline.
Patent CA-2758826-A1 (CA)
Title: Methods and gene expression signature for assessing ras pathway activity
Inventor: LOBODA ANDREY
IPC: G16B25/10
Filed: 2010-04-16
Abstract: Methods, biomarkers, and expression signatures are disclosed for assessing the regulation status of RAS pathway signaling in a cell sample or subject. More specifically, several aspects of the invention provide a set of genes which can be used as biomarkers and gene signatures for evaluating RAS pathway deregulation status in a sample; classifying a cell sample as having a deregulated or regulated RAS signaling pathway; determining whether an agent modulates the RAS signaling pathway in sample;  predicting response of a subject to an agent that modulates the RAS signaling pathway; assigning treatment to a subject; and evaluating the pharmacodynamic effects of cancer therapies designed to regulate RAS pathway signaling.
Patent CA-2759395-A1 (CA)
Title: Method and apparatus for secure packet transmission
Inventor: MURRILL LARRY
IPC: H04L29/06
Filed: 2010-04-20
Abstract: A source endpoint includes a security association database; a processing device and an interface operatively coupled to:  receive (306) a first packet requiring security processing; retrieve (308) from the first packet a destination endpoint data address for a destination endpoint that is to receive the first packet; determine (318) an address translation; apply (320) the address translation to the retrieved destination endpoint data address to generate a destination endpoint security address, and create (322) an entry in a storage device, wherein the entry corresponds only to the destination endpoint and comprises the generated destination endpoint security address and a set of security parameters. The source endpoint further indexes (324) the storage device to obtain the security parameters for security processing of the first packet to generate (326) a secured first packet; and sends (328) the secured first packet to the destination endpoint.
Patent CA-2760744-A1 (CA)
Inventor: BROCKER ERICH
IPC: A61J3/07
Filed: 2010-03-24
Abstract: The present invention relates to a rotary die device for producing soft capsules, comprising a capsule forming unit for forming a soft-capsule shell and a dosing unit for feeding a filling material into the capsule forming unit, characterized in that the dosing unit comprises a conveying apparatus of viscous melts and a portioner, wherein the portioner is connected at an end thereof to the conveying apparatus of viscous melts and is arranged in a filling wedge with a section in such a way that filling material from the portioner reaches the location of the capsule filling directly or by means of one or more channels having a length of at most 30 mm. Using said device, high-viscosity filling materials can be filled and thus novel soft capsules can be made accessible.
Patent CA-2762361-A1 (CA)
Title: Novel sterically hindered amine light stabilizers
Inventor: SCHOENING KAI-UWE
IPC: C07D471/10
Filed: 2010-06-01
Abstract: The instant invention pertains to sterically hjndered amine Nght stabilizers (HALS) with low basicity at the nitrogen atom and high thermal stability. They are characterized by their spiro-substitution in the 4-position of the tetramethylpiperidine ring (Spiro-NOR-HALS). These compounds are particularly effective in stabilizing polymers, especially thermoplastic poly-olefins, against the deleterious effects of oxidative, thermal and actinic radiation.  The compounds are also particularly effective in stabilizing acid catalyzed and ambient cured coatings systems. They are particularly useful when high processing temperatures are additional required.
Patent CA-2762586-A1 (CA)
Inventor: DAFTARIAN PIROUZ MOHAMMAD
IPC: C12N15/87
Filed: 2010-05-19
Abstract: Compositions, assays, kits, methods and platforms for delivering an antigen (peptides, proteins) or a nucleic acid encoding an antigen to professional APCs (PAPCs) are described which are ued in assessing the ef-ficacy of a vaccine (e g, a cytotoxic T lymphocyte (CTL) response to a particular antigen) or other therapy or inter-vention (cell-based therapy, adjuvant therapy, etc ) The composition, kits, assays and methods involve the com-bined use of MHC targeting, universal DR binding pep-tides (e g, PADRE, HA) with charged (e g, positively--charged) highly branched polymeric dendrimers (e g, PA-MAM and other dendrimers) as vehicles for the targeted delivery of nucleic acids, peptides, biologies, drugs, or polypeptides to APCs.
Patent CA-2762797-A1 (CA)
Title: Electronically controlled locking differential having under-dash control system
Inventor: DAYTON TERRY ANDREW
IPC: B60K23/04
Filed: 2010-05-20
Abstract: An electronically controlled locking differential (10) includes an electromagnetic coil (50) and a control system (56) adapted to control operation of the differential (10). The control system (56) has a module (58) adapted to be mounted under a dashboard of a vehicle and a circuit (78) electrically interfacing with the module (58). The circuit (78) has a latching switch (64) that is electrically connected to first and/or second sources of power and adapted to provide latching power of the differential (10).  A latching component (84) is electrically connected to the latching switch (64) and adapted to provide latching power of the differential (10). The circuit (78) is disabled when power to the control system (56) is turned off and in "standby" mode when power to the control system (56) is turned on. Upon the latching switch (64) being activated, current flows through the circuit (78) to activate the latching component (84), and the differential (10) is actuated.
Patent CA-2766961-A1 (CA)
Inventor: GYRN STEFFEN
IPC: G01R3/00
Filed: 2010-08-06
Abstract: The invention concerns a base part for a medication delivery device. The base part is during use fastened to a patient's skin and connected to a cannula part which cannula part is positioned at least partly subcutaneous. The base part is also connected to a sensor unit which can detect one or more components e.g. glucose content in the patients blood. The base part comprises fastening means (15) which fastening means (15) releasably attach the reservoir/delivery part to the base part during use and a first fluid path or means corresponding to a first fluid path from a reservoir permitting a flow of fluid between the reservoir/delivery part and the base part when the reservoir/delivery part is attached to the base part, the first fluid path comprises means (17) for interrupting the fluid flow when the detachable reservoir/delivery part is not attached to the base part (1) and opening the fluid path (19) when the delivery part is attached to the base part (1). The base part (1) also comprises a lower mounting surface (2) and one or more openings (12A, 12C) through which two or more subcutaneous units (7,70) in the form of at least one cannula and at least one sensor part or at least two cannulas extend and it comprises a second fluid path permitting a flow of fluid from the outlet of the first fluid path to an inlet of a subcutaneously positioned cannula (22, 22a, 22b) during use, and a signal path is provided from the reservoir/delivery part to a sensor contact part. The base part is characterized in that the second fluid path is in fluid connection with an end opening of a subcutaneously positioned cannula during use.
Patent CA-2767360-A1 (CA)
Inventor: STEINTHORSDOTTIR VALGERDUR
IPC: C12Q1/68
Filed: 2010-07-09
Abstract: The invention relates to variants that predispose to risk of type 2 diabetes, basal cell carcinoma and breast cancer. It has been discovered that certain genetic variants confer risk of these diseases when inherited from one parent, but not the other. The invention provides methods of disease management, including diagnostic methods, utilizing such parental origin effects. 5
Patent CA-2768155-A1 (CA)
Inventor: WATTS ANDREW GRAHAM
IPC: A61K47/48
Filed: 2010-06-16
Abstract: Techniques to glycosylation are described, and more particularly to the production of glycosylation structures that are resistant to enzymatic degradation, thereby modulating one or more of their biological properties or those of therapeutic moieties incorporating them, and in particular to reacting activated carbohydrate substrates containing fluorine, such as 3-fluoro sialic acid compounds, with sugar acceptors to produce covalent conjugates of the sugar acceptor and one or more of the sialic acid compounds.
Patent CA-2770918-A1 (CA)
Title: Communication technique by which an autonomous guidance system controls an industrial vehicle
Inventor: HARVEY DEAN S
IPC: B60W30/14
Filed: 2012-03-08
Abstract: A propulsion drive system is operated by a controller to propel an industrial vehicle along a path in an unmanned mode. An autonomous processor module sends commands to the vehicle controller in response to messages received via a communication network from a guidance and navigation system. The guidance and navigation system transmits a message over the communication network, wherein that message contains a first numerical value specifying the velocity and a second numerical value specifying an amount that the propulsion drive system is to turn a wheel of the industrial vehicle. The message also specifies a maximum speed limit and indicators commanding that a load carried by the industrial vehicle be raised and lowered. The autonomous processor module transmits a feedback message indicate actual vehicle operating parameters to the guidance and navigation system.
Patent CA-2770939-A1 (CA)
Title: Medicinal biosecurity auto disposable syringe
Inventor: POVEDA ESTEPA LUIS ENRIQUE
IPC: A61M5/20
Filed: 2010-06-16
Abstract: The present invention relates to a security syringe comprising a hollow cylinder (1) with a pair of wings (11) and a tip (12), which houses: the injection mechanism (3), a piston (2), and an injection mechanism (3) with a needle (31), a spring (32) and a membrane (33). The piston (2) has a serrated crown in the lower part (21) thereof where a chamber seal exists (22) and breaks only with the interior point of the needle (31), having the ends of the piston (2) of an inferior disk (24) and a superior disk (25) that steadies the piston (2) inside the cylinder (1). Around the cylinder (1) there is a protective funnel (13) against accidental injections. The piston comprises a cap (26) which guarantees the hermeticity of the empty chamber.
Patent CA-2770942-A1 (CA)
Title: Apparatus, system and method for emulsifying oil and water
Inventor: MANIERE OLIVIER
IPC: B01F25/46
Filed: 2009-08-04
Abstract: The invention relates to a device, system and method for emulsifying oil and water, so as to emulsify a gluing agent to be used in the treatment of paper or cardboard, involving feeding a continuous phase under pressure through a nozzle (66) providing a continuous phase of a Venturi device (50) and into a mixing section. A dispersed phase is optionally fed under pressure into the mixing section (80) of the Venturi device. The emulsion formed in the mixing section is channeled through a nozzle (60) for mixed phase and out of the Venturi device. The diameter of the nozzle (60) for a mixed phase of the Venturi device is greater than the diameter of the nozzle (66) for a continuous phase by a ratio greater than 1:1 and less than 4:1.
Patent CA-2771369-A1 (CA)
Title: Determining sensitivity of cells to b-raf inhibitor treatment by detecting kras mutation and rtk expression levels
Inventor: HATZIVASSILIOU GEORGIA
IPC: G01N33/48
Filed: 2010-08-24
Abstract: The present invention relates to prognostic methods for identifying tumors that are not susceptible to B-Raf inhibitor treatment by detecting mutations in a K-ras gene or protein or by detecting overexpression of RTKs and/or their ligands. Kits are also disclosed for carrying out the methods.
Patent CA-2771682-A1 (CA)
Title: Module arrangement consisting of solar modules
Inventor: SALZER WADIM
IPC: F24J2/52
Filed: 2010-09-07
Abstract: The invention relates to a module arrangement having the following: double module arrangements, each consisting of two solar modules oriented at an angle to each other; wherein the two solar modules (1) of the individual double module arrangements are coupled to each other at least in the region of their opposing upper edges; wherein the two solar modules (1) of each double module arrangement are coupled to each other via one or more connectors (6); wherein the connector (6) for connecting the two modules of a double module arrangement is formed at an angle and has two limbs (11,12) which form an angle a, said angle being between 95° and 175°; wherein one or more profiles (5) are arranged under the solar modules, and in particular under glass-glass thin film laminate modules, said profiles having one or more chambers, wherein adjacent double module arrangements are connected to each other via at least one or more coupling devices, said coupling devices having anti-slip devices (4). The one or more chambers of the profile or profiles (5) is or are designed to secure the connector (6, 7) by receiving said connector (6, 7).
Patent CA-2775605-A1 (CA)
Title: Methods using amphoteric surfactants
Inventor: PENG SHENG
IPC: C09K23/00
Filed: 2010-10-07
Abstract: |A method of providing a surface effect to a medium or substrate comprising contacting the medium or substrate with a compound of formula (I) : wherein Ra is linear or branched F(CF2)n(CH2CF2)m-, or linear or branched F(CF2)r-O-B-; B is (CsF2s) optionally interrupted by 1 to 2 catenary oxygen atoms, each oxygen bonded to two carbon atoms, n is 2 to 4, m is 1 to 4, r is 1 to 4, s is 1 to 4, provided that (r + s) is a maximum of 7, A is O or (CH2)k-COO, R1 is hydrogen or a methyl, R2 and R3 are each independently alkyl having 1 to 6 carbon atoms, and p, q and k are each independently integers from 1 to 10.
Patent CA-2775941-A1 (CA)
Inventor: GUILLOUX CYRIL
IPC: G02C7/02
Filed: 2010-09-29
Abstract: L'invention se rapporte à un procédé de détermination d'une lentille ophtalmique pour un porteur (i1, i2, i3) comprenant les étapes de : i) détermination de la taille (T1, T2, T3) ou de la hauteur des yeux (H1, H2, H3) du porteur; ii) calcul d'au moins une caractéristique de la lentille ophtalmique en fonction de la taille (T1, T2, T3) ou de la hauteur des yeux (H1, H2, H3) du porteur. La lentille ophtalmique peut être du type à progression de puissance ou du type unifocale. L'invention concerne également un procédé d'optimisation et un procédé de fabrication d'une lentille ophtalmique mettant en uvre un tel procédé de définition. L'invention vise également un ensemble de lentilles dont au moins une caractéristique est fonction de la taille ou de la hauteur des yeux des porteurs.
Patent CA-2777362-A1 (CA)
Title: Method to control spider mites
Inventor: GRBIC MIODRAG
IPC: C12N15/82
Filed: 2010-10-13
Abstract: The present invention relates to a method to control spider mites on plants. More specifically, the invention relates to plants, expressing RNAi of one or more essential genes of the spider mite, and the use of those plants to control the spider mite proliferation into pest proportions. In a preferred embodiment, the spider mite is Tetranychus urticae.
Patent CA-2777744-A1 (CA)
Title: Recombinant modified vaccinia ankara (mva) vaccinia virus containing restructured insertion sites
Inventor: MOSS BERNARD
IPC: C07K14/16
Filed: 2010-10-15
Abstract: The present invention relates to recombinant modified vaccinia Ankara (MVA) virus containing restructured sites useful for the integration of heterologous nucleic acid sequences into an intergenic region (IGR) of the virus genome, where the IGR is located between two adjacent, essential open reading frames (ORFs) of the vaccinia virus genome, wherein the adjacent essential ORFs are non-adjacent in a parental MVA virus used to construct the recombinant MVA virus, and to related nucleic acid constructs useful for inserting heterologous DNA into the genome of a vaccinia virus, and further to the use of the disclosed viruses as a medicine or vaccine.